BACKGROUND: Clinically it is recognized that tree nut allergies such as hazelnut allergy are not usually outgrown. Specific mechanisms underlying the persistence of such food allergies are incompletely understood. Here we studied the natural history and the long-term immune and clinical characteristics of hazelnut allergy in an adjuvant-free mouse model. METHODS: BALB/c mice were sensitized to hazelnut protein using a transdermal sensitization protocol that does not use adjuvant. After establishing sensitization, exposure to hazelnut was withdrawn for 3, 5 or 8 months. The fate of circulating IgE antibodies was monitored. Subsequently, mice were given booster exposures and examined for memory IgE antibody and spleen cell IL-4 responses. Clinical characteristics and hypothermia responses upon oral allergen challenge were studied. RESULTS: Upon allergen withdrawal, circulating hazelnut-specific IgE antibody levels began to drop. Nevertheless, IgE responses once established remained at significantly high levels for up to 8 months (the last time point studied) despite withdrawal of allergen exposure. Memory IgE responses to booster exposures were robust after 3, 5 or 8 months of allergen withdrawal. Furthermore, significant clinical reactivity to oral hazelnut challenge, and hypothermia responses were demonstrable at each of these time points. Long-lasting spleen cell memory IL-4 responses to hazelnut were detectable in these mice explaining the mechanism of sustenance of IgE responses and clinical sensitization. CONCLUSIONS: Hazelnut allergy once established persists for long periods, despite withdrawal of allergen exposure, due to long-lasting, memory IgE and IL-4 responses. 2010 S. Karger AG, Basel.
BACKGROUND: Clinically it is recognized that tree nut allergies such as hazelnut allergy are not usually outgrown. Specific mechanisms underlying the persistence of such food allergies are incompletely understood. Here we studied the natural history and the long-term immune and clinical characteristics of hazelnut allergy in an adjuvant-free mouse model. METHODS: BALB/c mice were sensitized to hazelnut protein using a transdermal sensitization protocol that does not use adjuvant. After establishing sensitization, exposure to hazelnut was withdrawn for 3, 5 or 8 months. The fate of circulating IgE antibodies was monitored. Subsequently, mice were given booster exposures and examined for memory IgE antibody and spleen cell IL-4 responses. Clinical characteristics and hypothermia responses upon oral allergen challenge were studied. RESULTS: Upon allergen withdrawal, circulating hazelnut-specific IgE antibody levels began to drop. Nevertheless, IgE responses once established remained at significantly high levels for up to 8 months (the last time point studied) despite withdrawal of allergen exposure. Memory IgE responses to booster exposures were robust after 3, 5 or 8 months of allergen withdrawal. Furthermore, significant clinical reactivity to oral hazelnut challenge, and hypothermia responses were demonstrable at each of these time points. Long-lasting spleen cell memory IL-4 responses to hazelnut were detectable in these mice explaining the mechanism of sustenance of IgE responses and clinical sensitization. CONCLUSIONS: Hazelnut allergy once established persists for long periods, despite withdrawal of allergen exposure, due to long-lasting, memory IgE and IL-4 responses. 2010 S. Karger AG, Basel.
Authors: Arne Høst; Susanne Halken; Hans P Jacobsen; Anne E Christensen; Anne M Herskind; Karin Plesner Journal: Pediatr Allergy Immunol Date: 2002 Impact factor: 6.377
Authors: R P Schade; A G Van Ieperen-Van Dijk; F C Van Reijsen; C Versluis; J L Kimpen; E F Knol; C A Bruijnzeel-Koomen; E Van Hoffen Journal: J Allergy Clin Immunol Date: 2000-12 Impact factor: 10.793
Authors: H S Skolnick; M K Conover-Walker; C B Koerner; H A Sampson; W Burks; R A Wood Journal: J Allergy Clin Immunol Date: 2001-02 Impact factor: 10.793
Authors: Teresa Boyano-Martínez; Carmen García-Ara; José María Díaz-Pena; Manuel Martín-Esteban Journal: J Allergy Clin Immunol Date: 2002-08 Impact factor: 10.793
Authors: Ovidiu Ivanciuc; Steven M Gendel; Trevor D Power; Catherine H Schein; Werner Braun Journal: Regul Toxicol Pharmacol Date: 2011-03-21 Impact factor: 3.271
Authors: Michiko K Oyoshi; Hans C Oettgen; Talal A Chatila; Raif S Geha; Paul J Bryce Journal: J Allergy Clin Immunol Date: 2014-02 Impact factor: 10.793
Authors: Yining Jin; Haoran Gao; Rick Jorgensen; Jillian Salloum; Dan Ioan Jian; Perry K W Ng; Venugopal Gangur Journal: Int J Mol Sci Date: 2020-05-01 Impact factor: 5.923
Authors: Rick Jorgensen; Rajsri Raghunath; Haoran Gao; Eric Olson; Perry K W Ng; Venu Gangur Journal: Int J Mol Sci Date: 2022-06-10 Impact factor: 6.208
Authors: Jungang Xie; Larisa C Lotoski; Rishma Chooniedass; Ruey-Chyi Su; F Estelle R Simons; Joel Liem; Allan B Becker; Jude Uzonna; Kent T HayGlass Journal: PLoS One Date: 2012-10-11 Impact factor: 3.240